Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Beclomethasone Dipropionate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

52 API Suppliers, 18 USDMF, 12 CEP/COS, 2 JDMF, 4 EU WC, 3 KDMF, 14 NDC API, 33 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

169 FDF Dossiers, 14 FDA Orange Book, 91 Europe, 7 Canada, 8 Australia, 14 South Africa, 35 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - EQ 0.042MG DIPROP/SPRAY, AEROSOL, METERED;NASAL - 0.04MG/ACTUATION, AEROSOL, METERED;NASAL - 0.08MG/ACTUATION, AEROSOL, METERED;INHALATION - 0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.08MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 2 DKSH, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 6 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 4 Kerry, 1 Kima Chemical, 6 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 1 Prachin Chemical, 8 Roquette, 6 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 1 The Dow Chemical Company, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

16 Fillers, Diluents & Binders, 16 Thickeners and Stabilizers, 15 Solubilizers, 9 Direct Compression, 7 Parenteral, 7 Co-Processed Excipients, 6 Rheology Modifiers, 5 Disintegrants & Superdisintegrants, 5 Granulation, 5 Controlled & Modified Release, 4 Film Formers & Plasticizers, 4 Coating Systems & Additives, 3 Taste Masking, 3 Topical, 3 Emulsifying Agents, 2 Surfactant & Foaming Agents, 2 Chewable & Orodispersible Aids, 1 API Stability Enhancers, 1 Lubricants & Glidants

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 17 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 79 Regulatory FDF Prices, 4 Annual Reports

MARKET PLACE

13 APIs, 2 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

52 US Patents, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 1 JP, 3 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
28/03/2025	Axplora	Germany	Kolon Pharmaceutical Co., Ltd.	20130610-186-I-285-01	Beclomethasone dipropionate	2013-06-10	Farmabios SpA	Italy	Gropello Cairoli (PV) - Via Pavia, 1, Italy.
28/03/2025	Avik Pharmaceutical Limited	India	Hiple Co., Ltd.	20200807-186-I-610-03	Beclomethasone dipropionate	2020-08-07	AVIK Pharmaceutical. Ltd	India	A-1/7, 1St Phaes, GIDC, City: VAPI - 396 195, Dist. Valsad Gujarat State India

Beclomethasone Dipropionate

Beclomethasone Dipropionate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

52 API Suppliers

18 USDMF

12 CEP/COS

2 JDMF

4 EU WC

3 KDMF

14 NDC API

33 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

169 FDF Dossiers

14 FDA Orange Book

91 Europe

7 Canada

8 Australia

14 South Africa

35 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - EQ 0.042MG DIPROP/SPRAY

AEROSOL, METERED;NASAL - 0.04MG/ACTUATION

AEROSOL, METERED;NASAL - 0.08MG/ACTUATION

AEROSOL, METERED;INHALATION - 0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, METERED;INHALATION - 0.08MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

1 SPI Pharma

2 DKSH

2 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

6 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 BASF

2 DFE Pharma

1 Finar

6 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

4 Kerry

1 Kima Chemical

6 Microlex e.U

1 Nanjing Bold Chemical

1 Pharmatrans-Sanaq

1 Pluviaendo

1 Prachin Chemical

8 Roquette

6 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

8 Sigachi Industries

1 The Dow Chemical Company

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

16 Fillers, Diluents & Binders

16 Thickeners and Stabilizers

15 Solubilizers

9 Direct Compression

7 Parenteral

7 Co-Processed Excipients

6 Rheology Modifiers

5 Disintegrants & Superdisintegrants

5 Granulation

5 Controlled & Modified Release

4 Film Formers & Plasticizers

4 Coating Systems & Additives

3 Taste Masking

3 Topical

3 Emulsifying Agents

2 Surfactant & Foaming Agents

2 Chewable & Orodispersible Aids

1 API Stability Enhancers

1 Lubricants & Glidants

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

AEROSOL, METERED;INHALATION - 0.04MG/INH Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

AEROSOL, METERED;INHALATION - 0.08MG/INH Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons